BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression
复制标题
DOI:
10.1172/jci66517
复制
发表时间:
2013-04-01
影响因子:
15.9
通讯作者:
Ghobrial, Irene M.
中科院分区:
文献类型:
--
作者:
Roccaro, Aldo M.;Sacco, Antonio;Ghobrial, Irene M.
BM mesenchymal stromal cells (BM-MSCs) support multiple myeloma (MM) cell growth, but little is known about the putative mechanisms by which the BM microenvironment plays an oncogenic role in this disease. Cell-cell communication is mediated by exosomes. In this study, we showed that MM BM-MSCs release exosomes that are transferred to MM cells, thereby resulting in modulation of tumor growth in vivo. Exosomal microRNA (miR) content differed between MM and normal BM-MSCs, with a lower content of the tumor suppressor miR-15a. In addition, MM BM-MSC-derived exosomes had higher levels of oncogenic proteins, cytokines, and adhesion molecules compared with exosomes from the cells of origin. Importantly, whereas MM BM-MSC-derived exosomes promoted MM tumor growth, normal BM-MSC exosomes inhibited the growth of MM cells. In summary, these in vitro and in vivo studies demonstrated that exosome transfer from BM-MSCs to clonal plasma cells represents a previously undescribed and unique mechanism that highlights the contribution of BM-MSCs to MM disease progression.